ABC transporter-mediated multidrug-resistant cancer
ATP-binding cassette (ABC) transporters are involved in active pumping of many diverse
substrates through the cellular membrane. The transport mediated by these proteins …
substrates through the cellular membrane. The transport mediated by these proteins …
The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer
This review addresses the oncopharmacological properties of curcumin at the molecular
level. First, the interactions between curcumin and its molecular targets are addressed on …
level. First, the interactions between curcumin and its molecular targets are addressed on …
Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies
CM Hattinger, MP Patrizio, L Fantoni, C Casotti… - Cancers, 2021 - mdpi.com
Simple Summary Despite the adoption of aggressive, multimodal treatment schedules, the
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …
Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
SPC Cole - Annual review of pharmacology and toxicology, 2014 - annualreviews.org
The human ATP-binding cassette transporter multidrug resistance protein 1 (MRP1),
encoded by ABCC1, was initially identified because of its ability to confer multidrug …
encoded by ABCC1, was initially identified because of its ability to confer multidrug …
Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies
L Amiri-Kordestani, A Basseville, K Kurdziel… - Drug Resistance …, 2012 - Elsevier
This special issue of Drug Resistance Updates is dedicated to multidrug resistance protein 1
(MDR-1), 35 years after its discovery. While enormous progress has been made and our …
(MDR-1), 35 years after its discovery. While enormous progress has been made and our …
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
Introduction: Most disseminated cancers remain fatal despite the availability of a variety of
conventional and novel treatments including surgery, chemotherapy, radiotherapy …
conventional and novel treatments including surgery, chemotherapy, radiotherapy …
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
S Wu, L Fu - Molecular cancer, 2018 - Springer
Multidrug resistance (MDR) triggered by ATP binding cassette (ABC) transporter such as
ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no …
ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no …
[HTML][HTML] Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives
Cancer, a major public health problem, is one of the world's top leading causes of death.
Common treatments for cancer include cytotoxic chemotherapy, surgery, targeted drugs …
Common treatments for cancer include cytotoxic chemotherapy, surgery, targeted drugs …
[HTML][HTML] Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy
W Xu, C Ye, X Qing, S Liu, X Lv, W Wang, X Dong… - Materials Today Bio, 2022 - Elsevier
Abstract Multi-target Tyrosine Kinase Inhibitors (MTKIs) have drawn substantial attention in
tumor therapy. MTKIs could inhibit tumor cell proliferation and induce apoptosis by blocking …
tumor therapy. MTKIs could inhibit tumor cell proliferation and induce apoptosis by blocking …
Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
S Shukla, ZS Chen, SV Ambudkar - Drug resistance updates, 2012 - Elsevier
Tyrosine kinases (TKs) are involved in key signaling events/pathways that regulate cancer
cell proliferation, apoptosis, angiogenesis and metastasis. Deregulated activity of TKs has …
cell proliferation, apoptosis, angiogenesis and metastasis. Deregulated activity of TKs has …